Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety Surveillance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00488800
What this trial is testing

Safety and Local Tolerability of Prevenar in Indian Children

Who this might be right for
Pneumococcal Infections
Wyeth is now a wholly owned subsidiary of Pfizer 1,000
Not applicableLooking for participantsNCT06073873
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 3,000
Not applicableStudy completedNCT03412110
What this trial is testing

(MIST2)-Part2: AEs Following DC Care at DC Teaching Clinic: Electronic

Who this might be right for
Patient SafetyManipulation, Spinal
Parker University 416
Not applicableStudy completedNCT01763008
What this trial is testing

The Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

Who this might be right for
Pneumonia, BacterialNosocomial InfectionIntraabdominal Infections+1 more
Janssen Pharmaceutica 170
Not applicableEnrolling By InvitationNCT06109935
What this trial is testing

Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

Who this might be right for
Growth Hormone Deficiency in Children
Novo Nordisk A/S 200
Post-approval studies (Phase 4)Study completedNCT05054387
What this trial is testing

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 22
Not applicableStudy completedNCT01053429
What this trial is testing

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 3,391
Not applicableEnded earlyNCT01073644
What this trial is testing

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 3
Not applicableStudy completedNCT02489331
What this trial is testing

Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

Who this might be right for
Dyslipidemias
Abbott 193
Not applicableStudy completedNCT03672929
What this trial is testing

Allofit® IT With HXPE in Total Hip Arthroplasty

Who this might be right for
Avascular NecrosisOsteoarthritis, HipInflammatory Arthritis+1 more
Zimmer Biomet 197
Not applicableStudy completedNCT00612885
What this trial is testing

Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study

Who this might be right for
OsteoarthritisArthritis, Rheumatoid
Boehringer Ingelheim 425
Not applicableStudy completedNCT04178317
What this trial is testing

The Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

Who this might be right for
Cancer, Chronic Lymphocytic Leukemia (CLL)
AbbVie 14
Not applicableLooking for participantsNCT06073847
What this trial is testing

A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Bristol-Myers Squibb 137
Not applicableStudy completedNCT02385721
What this trial is testing

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 601
Not applicableLooking for participantsNCT00414115
What this trial is testing

National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

Who this might be right for
Adverse Drug Reaction (ADR)
University of British Columbia 7,000
Not applicableLooking for participantsNCT06760208
What this trial is testing

Learn More About Prevenar 20 Once it is Out in the Korean Market

Who this might be right for
Pneumococcal ImmunizationSafety
Pfizer 660
Not applicableStudy completedNCT04632056
What this trial is testing

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 329
Not applicableStudy completedNCT03001115
What this trial is testing

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

Who this might be right for
Hidradenitis Suppurativa (HS)
AbbVie 17
Not applicableLooking for participantsNCT06236750
What this trial is testing

Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds

Who this might be right for
Diabetic Foot UlcerVenous Leg Ulcer
MiMedx Group, Inc. 75
Post-approval studies (Phase 4)Active Not RecruitingNCT07223723
What this trial is testing

Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 12
Next Page